- A doctor recommended semaglutide to Lisandra Silva, 37 years old.
- He now follows a healthy diet and exercise regimen to lose weight.
- READ MORE: ‘Natural’ alternatives to Ozempic, according to experts
A popular Cuban influencer who dabbled in Ozempic stated that the drug made her “feel like she was dying.”
Lisandra Silva, 37, spoke about her experience with semaglutide in an Instagram post shared with her two million followers over the weekend.
‘How low did Ozempic go?’ he wrote in the post, which was translated into English by people magazine.
‘Do you know who recommended it to me? A doctor. And I tell you that I put it on once to try it, because they talked a lot about it and I ended up in the hospital,’ he continued.
“My sugar level dropped so low that I had to call the kids’ dad when I felt like I was fainting and my kids were sleeping next to me.”
Cuban influencer and reality star Lisandra Silva was hospitalized after taking Ozempic
And he added: “Thank God nothing happened, but I felt like I was dying and I ended up in the clinic in a wheelchair.”
After her terrible experience with diabetes medication, the Double Temptation star turned to exercise to lose weight.
She also follows the Ayurvedic diet, which prioritizes whole foods and mindful eating.
When it comes to working out, Silva combines the gym with outdoor exercise.
‘Please listen to my advice! There’s nothing like a healthy lifestyle! DON’T MAKE IT UP!’ he urged his followers.
Silva is best known for winning the first season of the Chilean reality television series Doble Tentación in 2017.
Earlier this year, Lottie Moss was rushed to hospital after overdosing on Ozempic.
After her ordeal with diabetes medication, the Double Temptation star turned to exercise and a healthy diet to lose weight. In the photo: before losing weight (left) and after (right)
When it comes to exercising, Silva combines the gym with outdoor exercise
Silva is best known for winning the first season of the Chilean reality show Doble Tentación in 2017.
The model, 26, was seriously ill, suffered seizures and was severely dehydrated while taking the medication when she weighed around 60kg (just four kilos).
A friend gave him the vaccine and he bought it from a doctor without a prescription, he said.
Ozempic stimulates weight loss by mimicking the actions of a hormone released in the intestine after eating, called GLP-1.
In addition to telling the pancreas to produce more insulin, the GLP-1 hormone feeds back to the brain and makes users feel full.
As a result, semaglutide may prevent users from overeating.
But it is not without side effects: users often complain of nausea, constipation and diarrhea after taking the medication.
Unlike the hormone GLP-1, which the body metabolizes quickly, semaglutide has a much longer half-life, meaning the drug can build up inside the body if not enough time passes between doses, which can lead to an overdose. .
